Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Invasive pneumonia and antibiotic resistance decreased after childhood vaccine introduced

18.03.2005


Scientists at Emory University and the Georgia Emerging Infections Program find powerful positive effect on both children and unvaccinated adults



The problem of increasing antibiotic resistance in cases of Streptococcus pneumoniae, a major cause of pneumonia, meningitis and sepsis, was dramatically reversed following the licensing and use of a new conjugate vaccine for young children in February 2000, according to research conducted at Emory University, the Atlanta Veterans Affairs Medical Center, the Centers for Disease Control and Prevention, and the Georgia Division of Public Health. The researchers also found a significant decrease in the incidence of invasive pneumococcal disease in both vaccinated children and unvaccinated adults after the vaccine was introduced.

The research, led by David S. Stephens, MD, professor and vice chair of medicine and division director of infectious diseases in Emory University School of Medicine, was published in the March 5, 2005 issue of The Lancet.


Following approval of the seven-valent pneumococcal conjugate vaccine for young children in the U.S. in February 2000, the vaccine was in general use in Atlanta by the end of 2000. Antibiotic resistance in pneumonia, after increasing steadily in Atlanta from 4.5 per 100,000 in 1994 to 9.3 per 100,000 in 1999 (more than 25 percent of invasive pneumococcal isolates), fell to 2.9 per 100,000 by 2002. The incidence of invasive pneumonia in Atlanta fell from a mean annual incidence of 30.2 per 100,000 in the period January 1994 to December 1999 to 13.1 per 100,000 in 2002.

The most striking reductions in invasive pneumococcal disease were in the youngest children, which also was the age group targeted to receive the vaccine. Children younger than two years old experienced an 82 percent decrease in invasive disease, and children two to four years old had a 71 percent decrease.

In addition to declining rates of pneumonia in young children, the researchers also found significant drops in adults aged 20-39 (54 percent), 40-64 (25 percent) and 65 and older (39 percent) who did not receive vaccine, an effect known as "herd immunity."

Increases in antibiotic resistance by S. pneumoniae are also a problem in other parts of the U.S., Canada, Europe, Africa and Asia. Resistance increased dramatically after the introduction and widespread use of new macrolide antibiotics such as azithromycin and clarithromycin, especially in children younger than five years.

The Atlanta research team studied pneumococcal isolates and demographic data from patients with invasive disease. They calculated cumulative incidence rates for invasive pneumonia from 1994 to 2002 using population estimates and census data from the U.S. Census Bureau.

The decline in invasive pneumococcal disease and in macrolide resistance occurred even though there were substantial shortages of the childhood vaccine between 2001 and 2003. "The decline in antibiotic resistance in invasive pneumococci in Atlanta between 2000 and 2002 was the result of introducing the pneumococcal conjugate vaccine," says Dr. Stephens. "The vaccine had both direct and herd immunity effects as shown by the striking decline in disease incidence in children under five years, as well as in adults who were not vaccinated."

Other possible explanations for the reductions in invasive disease and antibiotic resistance were not convincing, Dr. Stephens notes. "Our study showed just how quickly vaccines can become effective in overcoming antibiotic resistance, but also just how quickly antibiotic resistance can spread when antibiotics are used inappropriately. It will be important to continue combining vaccines with programs that emphasize appropriate use of antibiotics."

Holly Korschun | EurekAlert!
Further information:
http://www.emory.edu

More articles from Health and Medicine:

nachricht GLUT5 fluorescent probe fingerprints cancer cells
20.04.2018 | Michigan Technological University

nachricht Scientists re-create brain neurons to study obesity and personalize treatment
20.04.2018 | Cedars-Sinai Medical Center

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Spider silk key to new bone-fixing composite

University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.

Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.

Im Focus: Writing and deleting magnets with lasers

Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...

Im Focus: Gamma-ray flashes from plasma filaments

Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.

The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...

Im Focus: Basel researchers succeed in cultivating cartilage from stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...

Im Focus: Like a wedge in a hinge

Researchers lay groundwork to tailor drugs for new targets in cancer therapy

In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

IWOLIA: A conference bringing together German Industrie 4.0 and French Industrie du Futur

09.04.2018 | Event News

 
Latest News

Magnetic nano-imaging on a table top

20.04.2018 | Physics and Astronomy

Start of work for the world's largest electric truck

20.04.2018 | Interdisciplinary Research

Atoms may hum a tune from grand cosmic symphony

20.04.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>